Rai AT, et al. - Among patients with acute ischemic stroke who had endovascular therapy (ET) between 2011 and 2017, researchers sought to assess trends in length of stay, discharge status, and costs via the Mann-Kendall trend test. Using a retrospective observational study design, the Premier Healthcare Database was used to identify 505,824 patients with acute ischemic stroke, 11,811 of whom were treated with ET. There was a substantial rise in home discharge and a substantial decline in mortality among patients receiving ET. A significant decline in the length of stay was noted from 11.7 days to 8.7 days. Data reported that total index admission costs declined ≈17% from 2011 to 2017 ($50,516.5–$42,026.9). Overall, the authors concluded that clinical and economic indicators improved significantly between 2011 and 2017 for patients with acute ischemic stroke undergoing ET.